AbbVie (NYSE: ABBV) completed its acquisition of Capstan Therapeutics on August 19, 2025, according to a company statement.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE